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Abstract
Background Coronary artery spasm may be the underlying mechanism in up to 10% of cases of acute coronary syndrome
(ACS) and sudden cardiac death. Asian individuals exhibit a 3-times greater incidence of spasm than Caucasians; this is
likely due to different types of mechanisms. Consequently, solid data is limited about the long-term prognosis in Caucasian
patients presenting with ACS and/or out-of-hospital cardiac arrest (OHCA) caused by coronary spasm.
Methods Between 2002 and 2015, thirty Caucasian patients with coronary artery spasm presenting with ACS (N =
29) and/or OHCA (N = 11) were enrolled in this prospective registry. Follow-up, consisting of regular outpatient visits,
was conducted with a mean follow-up period of 7.5 ± 3.3 years. Outcomes included presence of stable angina pectoris,
recurrence of ACS, occurrence of implantable cardioverter defibrillator (ICD) shocks and death.
Results The majority of patients (60%) remained asymptomatic during the entire follow-up period. At the end of the
follow-up period only 3 patients still experienced stable angina (10%). Only 2 patients (7%) had a recurrent cardiac
event, in which the ICD provided appropriate shock therapy. Half of the patients treated with stenting (N = 6), required
re-interventions.
Conclusion Coronary spasm with ACS and/or OHCA in a Caucasian patient cohort has a relatively benign prognosis in the
majority of patients in long-term follow-up, if treated appropriately with medical therapy. Both the role of ICD in OHCA
secondary to coronary spasm, and the efficacy of stenting to treat vasospastic angina, warrant further study in large-sized
prospective clinical trials.
Keywords Vasospastic angina · Coronary vasospasm · Acute coronary syndrome
Background
Coronary artery spasm may be the underlying mechanism
in up to 10% of cases of ischaemic heart disease, such as
unstable angina pectoris, acute myocardial infarction and
sudden cardiac death [1]. Coronary spasm is defined as an
abnormal contraction of a localised segment of an epicar-
dial artery (focal spasm), a dispersed contraction (diffuse
spasm), contraction of two or more segments of the same
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artery (multifocal spasm) or multiple coronary branches
(multivessel spasm) resulting in a dramatic reduction of
coronary blood flow, generating myocardial ischaemia [2].
Vasospasm may occur at sites of focal stenosis, but is often
documented in patients with apparently normal vessels at
angiography [3]. The typical syndrome caused by coronary
spasm is vasospastic angina, which most often occurs at
rest and at night (Prinzmetal’s variant angina) [4], but can
also be triggered by effort or stress conditions [5].
Vasospastic angina in Caucasian populations is relatively
uncommon, it is the underlying cause of a mere 1.5% of
all hospital admissions for (suspected) coronary artery dis-
ease [6]. In contrast, Asian individuals exhibit a 3-times
greater incidence of spasm than Caucasian patients [7, 8].
The pathogenic substrate of coronary spasms is multifacto-
rial [2]. Therefore, it is likely there is a difference in distri-
bution of these pathogenic substrates between people with
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Table 1 Protocol invasive coro-
nary reactivity testing using
acetylcholine
Dose ACh (mg/ml) Duration (min) Infusion speed (ml/hour)
Dose 1 “Low” 0.000211 3:00 min 82 ml/hour
Dose 2 “Medium” 0.002105
Dose 3 “High” 0.021053
Dose 4 “Provocation” 0.210526
Both calcium channel blockers and nitrates are discontinued 24 h prior to coronary reactivity testing. The
different doses of acetylcholine are administered intracoronary
ACh acetylcholine
an Asian or Caucasian genetic background. Consequently,
we can reasonably assume that there is an interracial differ-
ence in prognosis. Due to the low prevalence of vasospastic
angina in Caucasian populations, limited data are available
on the long-term follow-up of Caucasian patients with va-
sospastic angina, in particular in patients presenting with
serious complications of vasospastic angina, such as un-
stable angina pectoris, non-ST-segment-elevation myocar-
dial infarction (NSTEMI), ST-segment-elevation myocar-
dial infarction (STEMI) and/or out-of-hospital cardiac ar-
rest (OHCA). Therefore, the objective of this study was to
report and evaluate the long-term outcomes of Caucasian
patients diagnosed with acute coronary syndrome (ACS)
and/or out-of-hospital cardiac arrest (OHCA) secondary to
vasospastic angina.
Methods
Study design and patient population
The study was designed as a prospective single-centre
registry. We included a total of 30 consecutive patients
meeting the inclusion criteria presenting at the Academic
Medical Center (AMC), University of Amsterdam, be-
tween 2002 and 2015. Patients presenting with an acute
coronary syndrome and/or an out of hospital cardiac arrest,
caused by vasospastic angina were enrolled. All included
patients were suspected of vasospastic angina because of
their clinical presentation, in combination with an absence
of obstructive coronary artery disease at angiography. Per
protocol, all patients suspected of coronary spasm under-
went acetylcholine testing. We did not test patients with
evident coronary spasm prior to the acetylcholine testing
were not tested. Evident coronary spasm was considered
present in case of documented transient ischaemic elec-
trocardiographic signs in combination with the absence of
obstructive coronary artery disease, or spontaneous spasm
during diagnostic angiogram or provoked by wire manip-
ulation at the onset of acetylcholine testing. Patients with
non-Caucasian ancestry were excluded from the current
study, due to suspected different pathogenic substrates.
Cardiac catheterisation
Coronary angiography was performed through the femoral
or radial approach according to operators’ preference us-
ing a 6 French sheath. We started the procedure with the
administration of 5,000 i. e. units of heparin.
Acetylcholine testing
Coronary spasm can be provoked by acetylcholine, which
under normal circumstances dilates blood vessels [9].
However, in coronary arteries with endothelial dysfunc-
tion, acetylcholine induces a vasoconstrictive response
[10]. In case of an elective acetylcholine test, vasodilators
were discontinued 24 h before the cardiac catheterisation.
Acetylcholine chloride was infused in continuous incre-
mental doses (Table 1), into either the right coronary artery
or the left coronary artery depending on the clinical presen-
tation, until a spasm was provoked. In addition, if the first
infusions did not provoke spasm, the maximum dose was
provided. According to our institutional protocol, a Doppler
guide wire (either FloWire of ComboWire, both Volcano,
Rancho Cardova, Ca.) was introduced in the selected coro-
nary artery to document flow alterations after acetylcholine
testing and the early detection of cessation of blood flow
due to coronary vasospasm. A positive response to acetyl-
choline testing was defined as transient occlusion (>90%
narrowing) of a coronary artery with concomitant signs and
symptoms of myocardial ischaemia (ST changes/angina).
Fig. 1 displays examples of focal and diffuse coronary
spasm in the current patient cohort.
Definitions
The Coronary Vasomotion Disorders International Study
group (COVADIS) published the three core elements re-
quired to diagnose vasospastic angina [11], namely, tran-
sient ischaemic electrocardiographic changes, nitrate-re-
sponsive angina, and angiographic evidence of coronary
artery spasm. Vasospastic angina can also be diagnosed
without angiographic confirmation when an episode of
spontaneous angina, associated with transient ST-segment
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Fig. 1 Images of coronary
spasms, CAG coronary an-
giogram
elevation, that promptly reacts to short-acting nitrates is
observed.
Clinical follow-up and outcomes
We collected baseline demographic variables, procedural
and angiographic characteristics in a dedicated electronic
database. Follow-up was conducted actively in all patients
and consisted of regular outpatient visits to the cardiolo-
gist. Main outcomes collected during these visits included
the presence of stable angina pectoris, recurrence of ACS,
occurrence of implantable cardioverter defibrillator (ICD)
shocks and re-interventions. In case of admissions in other
hospitals, source documents were retrieved.
Statistical analysis
We reported patient characteristics as percentages, counts or
mean ± standard deviation (SD), where appropriate. Analy-
ses were performed using IBM SPSS version 23.0 software
(SPSS Inc, Chicago, IL).
Results
Patient characteristics
The patient characteristics of the study population (aged
56 ± 9 years, 50% women) are displayed in Table 2. In
total 8 patients presented with unstable angina pectoris
(27%), 3 with NSTEMI (10%), 18 with STEMI (60%)
and/or OHCA (N = 11, 24%).
Documentation of vasospastic angina
In 17 patients (57%) vasospastic angina was documented
by a positive acetylcholine test. In 7 patients (23%) va-
sospastic angina was documented either by a spontaneous
episode of coronary spasm at angiography or induced after
the introduction of a guide wire prior to acetylcholine test-
ing. In the remaining 6 patients (20%) vasospastic angina
was considered present because of dynamic electrocardio-
graphic changes and/or positive cardiac enzyme release in
the presence of angiographically normal coronary arteries.
In these 13 patients, acetylcholine testing was considered
redundant.
Angiographic characteristics
Patients with an angiographically documented coronary
spasm, showed a single vessel spasm in 16 patients ver-
sus multivessel spasm in 8 patients. Both in acetylcholine
provocation testing of the left coronary artery and in case
of a spontaneous spasm, the left anterior descending artery
was predominantly affected (Table 2). The distribution of
patients presenting with either diffuse spasm or focal spasm
was comparable (54% versus 46%). Furthermore, in the
total study cohort we found non-significant atherosclerotic
Neth Heart J (2018) 26:26–33 29
Table 2 Baseline patient characteristics and procedural and
angiographic data
N = 30
Demographics
Age 56 (±9)
Male 15 (50%)
Caucasian 30 (100%)
Risk factors/Medical history
Hypertension 11 (37%)
Dyslipidaemia 9 (30%)
Diabetes Mellitus 0 (–)
Smoking 7 (24%)
Ex-smoker 6 (20%)
– Family history of ischaemic heart
disease
8 (27%)
– Previous MI 8 (27%)
Presentation of coronary spasm
Unstable angina 8 (27%)
STEMI 18 (60%)
NSTEMI 3 (10%)
OHCA 11 (37%)
Clinical situation during presentation
In rest 25 (83%)
Physical effort or emotional distress 5 (17%)
Angiographic characteristics
IVUS/OCT use 16 (53%)
Coronary stenosis
Without stenosis 15 (50%)
Non-significanta 15 (50%)
Significant 0 (–)
Positive acetylcholine provocation
test
17 (57%)
Single vessel spasm (N = 11)
– LAD 7 (64%)
– RCA 3 (27%)
– CX 1 (3%)
Multivessel spasm (N = 6)
Spontaneous spasm-positive artery 7 (23%)
Single vessel spasm (N = 5)
– LAD 3 (60%)
– RCA 2 (40%)
– CX 0 (–)
Multivessel spasm (N = 2)
Spasm not objectified by
angiographyb
6 (20%)
Type of spasm (N = 24)
Diffuse 13 (54%)
Focal 11 (46%)
Multifocal 0 (–)
Treatment
ICD 8 (27%)
Table 2 Baseline patient characteristics and procedural and
angiographic data (Continued)
N = 30
Stenting (N = 6) 6 (20%)
– LAD 4 (67%)
– CX 1 (17%)
– RCA 1 (17%)
Medical treatment at discharge
Calcium channel blocker 26 (87%)
Long-acting nitrate 13 (43%)
Antiplatelet 28 (93%)
Statin 22 (73%)
ACEI/ARB 17 (57%)
Beta-blocker 1 (3%)
ACEI angiotensin-converting-enzyme inhibitor, ARB angiotensin
receptor blockers, Cx circumflex artery, ICD implantable car-
dioverter defibrillator, IVUS intravascular ultrasound, LAD left
anterior descending coronary artery, MI myocardial infarction,
NSTEMI non-ST-elevation myocardial infarction, RCA right coronary
artery, OHCA out-of-hospital cardiac arrest, OCT optimal coherence
therapy, STEMI ST-elevation myocardial infraction
aNon-significant stenosis defined as 25–50% diameter stenosis
bIn 6 patients, coronary spasm was considered because of dynamic
electrocardiographic changes and/or positive cardiac enzyme release
in the presence of angiographically normal coronary arteries.
Acetylcholine provocation testing was not performed in these patients
coronary stenosis in 15 patients (50%). Additional in-
travascular imaging using intravascular ultrasound (IVUS)
or optimal coherence therapy (OCT) was performed in 16
(53%) of the patients and showed intima hyperplasia or
minimal atherosclerotic disease (Fig. 2).
Treatment
The treating physicians prescribed calcium channel block-
ers in 26 (87%), long-acting nitrates in 13 (43%), anti-
platelet therapy in 28 (93%), statins in 22 (73%) and ACE-
inhibitors in 17 (57%) patients to treat the vasospastic
angina. A beta-blocker was prescribed in one patient (3%)
with persisting ventricular arrhythmias, despite a general
contraindication for beta-blockers in patients with coronary
spasm. Out of 11 patients who presented with OHCA, 8
(73%) received an ICD. In one patient, the treating physi-
cian deemed ICD implantation to be unnecessary since
the cardiac arrest was evidently provoked by surgery of
a neuro-endocrine tumour. In the remaining two patients
initially presenting with anteroseptal myocardial infarc-
tion and primary ventricular fibrillation, the responsible
clinicians considered ICD implantation to be non-benefi-
cial. Additionally, 6 patients (13%) were treated with stent
implantation. All six patients had documented vasospasm
as well as non-significant stenosis of the same segment,
in combination with ongoing angina, not responsive to
medication.
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Fig. 2 Image of intimal hyperplasia
Table 3 Follow-up
N = 30
Events
Asymptomatica 16 (53%)
Vasospastic angina
During follow-up period 12 (40%)
During the last year of the fol-
low-up period
3 (10%)
Death 1 (3%)
Cardiac death 0 (–)
ICD shock (N = 8) 3 (38%)
Appropriate shock 2 (25%)
Re-intervention (N = 6)b 3 (50%)
ICD implantable cardioverter defibrillator
aThe number of patients that were asymptomatic during the complete
follow-up period (no angina, no cardiac events and no appropriate ICD
shocks)
bDue to new spasm in the segment adjacent to the implanted stent (N =
2) or re-stenosis of bare metal stent (N = 1)
Long-term clinical outcomes
Patients were followed for a mean of 7.5 ± 3.3 year (Ta-
ble 3). During follow-up, 12 patients (40%) suffered from
stable angina pectoris. In only 3 patients (10%) the angina
persisted until the end of the follow-up period. More than
half of the patients (53%) did not experience angina, en-
countered no cardiac events and received no appropriate
ICD shock during the entire follow-up period. In 2 patients
who presented with an OHCA, ventricular fibrillation oc-
curred during follow-up, in both cases the ICD provided
appropriate shocks. Appropriate antiarrhythmic medication
was not adequately installed in one patient, while the other
patient was suspected of ongoing cocaine abuse. Addition-
ally, one patient who was asymptomatic during the en-
tire follow-up period received multiple inappropriate ICD
shocks. Of the 6 patients treated with stent implantation,
3 were asymptomatic after treatment. The remaining 3 pa-
tients required re-interventions due to new spasm in the
segment adjacent to the implanted stent (N = 2) or in-stent-
restenosis (N = 1). One patient died of non-cardiac disease
within the follow-up period.
Discussion
This present study shows, for the first time, the long-term
clinical follow-up of Caucasian patients with ACS and/or
OHCA as the initial presentation of vasospastic angina. Our
results indicate a relatively benign course of this disease in
most patients, if the disease is treated appropriately with
medical therapy.
Description of the cohort
The patient cohort described in this study is in line with
previous studies of patients with vasospastic angina, show-
ing endothelial dysfunction as determined by acetylcholine
testing, in the presence of minimal or mild atherosclerotic
disease in the majority of patients who underwent IVUS or
OCT. The long-term follow-up of this patient cohort showed
that a large part of the cohort remained symptomatic during
the initial one or two years following presentation, while the
symptoms disappeared beyond this period without relapse
of ACS or OHCA. Current guidelines do not support stent
implantation in vasospastic arteries without severe obstruc-
tive coronary narrowing, in particular in patients with severe
organic stenosis [10]. Stent implantation is only indicated
for those patients who are still symptomatic despite opti-
mal medical therapy, and in combination with focal steno-
sis. Although the number of patients studied is small, it is
an interesting observation that those patients treated with
stent implantation often required re-intervention due to va-
sospasm in the adjacent segments of the stent implantation.
This suggests that we should use stent implantation with
caution. Treating physicians implanted ICDs in 8 patients
with OHCA. Only two patients documented appropriate
ICD shocks, shortly after the initial event. These events
were presumably the consequence of cocaine abuse and in-
sufficient antiarrhythmic control. Interestingly, none of the
patients required additional ICD shocks after consistent ad-
ministration of adequate therapy. Nevertheless, the sample
size was too small to draw any conclusions regarding the
benefit of ICD implantation.
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Comparisonwith the literature
The majority of published studies focus on the underlying
mechanism of vasospastic angina in relation to the clinical
presentation. The largest database on vasospastic angina
in Caucasian patients comes from the WISE study group.
They emphasise the pivotal role of endothelial dysfunc-
tion as the pathological substrate in coronary artery spasm,
causing angina in the absence of epicardial disease [12].
Previous studies also evaluated the occurrence of cardiac
events during long-term follow-up in patients diagnosed
with vasospastic angina [13–16]. These studies concluded
that cardiac events occurred more often in patients with en-
dothelial dysfunction compared with patients without en-
dothelial dysfunction. But the studies did not provide data
on the use of calcium channel blockers [16], or treatment
with calcium channel blockers was not installed in the ma-
jority of patients [13]. Additionally, the studies showed that
gender and age differences play an important role in the
long-term outcomes of vasospastic angina [14]. Moreover,
diffuse spasm was associated with a better prognosis than
focal spasm.
Despite these follow-up studies, limited information is
available on the long-term follow-up of those patients who
presented with serious complications of vasospastic angina,
such as ACS. Few studies have addressed the prognosis of
patients with vasospastic angina presenting with a cardiac
arrest, these studies have different outcomes, small sample
sizes and/or short follow-up periods [17–20]. In a recent
study by Ahn et al. [21], long-term mortality and ventric-
ular tachyarrhythmic events in patients with aborted sud-
den cardiac death (ASCD) was investigated in a Korean
population. They concluded that the prognosis of patients
with vasospastic angina with ASCD was worse than other
patients with variant angina, despite optimal medical treat-
ment. Nevertheless, their study addressed a different pop-
ulation than the current study. First, their study solely in-
cluded patients presenting with cardiac arrest, whereas the
current study also enrolled patients with an acute coronary
syndrome, without a subsequent cardiac arrest. Second, in
the study by Ahn et al. only 13% of the patients received
an ICD, even though implantation is recommended in pa-
tients with an episode of resuscitated ventricular tachycar-
dia/ventricular fibrillation and a cause that is not completely
reversible. Therefore, this might have led to a higher mortal-
ity. Particularly, since they described a nonsignificant trend
of a lower rate of cardiac death in patients who did receive
ICD implantation. Third, the study by Ahn et al. obtained
8 years follow-up from only 20% of the enrolled population
with ASCD. In addition, another recent retrospective Ko-
rean cohort study by Cho et al. [22] described the follow-
up in a large cohort of patients with vasospastic angina,
as diagnosed with ergonovine provocation testing, present-
ing with ACS versus patients presenting without ACS. The
study concluded that patients initially presenting with ACS
had an increased risk of recurrent myocardial infarction
and rehospitalisation because of recurrent angina. However,
both studies address the Korean population, in which va-
sospastic angina has a higher incidence than in Caucasian
populations. A different pathophysiology could not be ruled
out [7]. This might explain the higher relapse rate of cardiac
events.
Comparison of the cohort with patients with
obstructive coronary artery disease
The low rates of recurrent cardiac events (1 in 15 patients)
in this study cohort stands in stark contrast to the high rates
of recurrence in patients with ACS and/or OHCA caused
by structural coronary artery disease. In the current study
population, most patients presented with STEMI and were
treated conservatively. Nevertheless, at the end of the fol-
low-up period, mortality and recurrence of cardiac events
were very low. In contrast, in the 5-year follow-up of the
ICTUS trial [23], 1 out of 5 patients with non-ST-segment-
elevation ACS treated with a selective invasive strategy had
experienced a myocardial infarction or died. This underlines
the difference between obstructive coronary artery disease
versus non-obstructive coronary artery disease.
Coronary spasm provocation testing
In the setting of endothelial dysfunction, provocation test-
ing causes contraction of smooth muscle cells. Provocation
testing to diagnose coronary spasm is not only important
to reassure the patient that a cause for the ACS is found, it
also allows the physician to provide adequate medical ther-
apy (starting calcium channel blockers and statins, possibly
nitrates and avoiding beta-blockers) and strongly stimulate
cessation of smoking. Almost one-third of the patients pre-
senting with ACS has unobstructed coronary arteries during
coronary angiography (CAG) [1]. Almost half (48%) of the
patients with ACS and unobstructed coronary arteries, show
coronary spasm during intracoronary acetylcholine testing.
Ergonovine testing is also frequently used to provoke coro-
nary spasm during CAG. However, ergonovine is suspected
to be less sensitive, resulting in false-negative outcomes
of the test [24, 25]. Additionally, acetylcholine testing is
relatively safe with complications (non-fatal arrhythmias)
occurring in 1% [25, 26]. Alternatively, coronary spasm
can be provoked with the cold pressor test, atrial pacing
and exercise and hyperventilation. Nevertheless, the sensi-
tivity and specificity of these tests are lower than ergonovine
and acetylcholine testing and therefore of limited diagnos-
tic value [27, 28]. In short, we recommend acetylcholine
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testing in all patients presenting with ACS who show un-
obstructed coronary arteries during CAG.
Study limitations
The first study limitation is that acetylcholine testing was
not performed in all studied patients. Nevertheless, coronary
spasm was considered present because of dynamic electro-
cardiographic changes and/or positive cardiac enzyme re-
lease in the presence of angiographically normal coronary
arteries. Also, the number of patients studied was relatively
small, although these patients were followed for a lengthy
period (a mean follow-up period of almost 8 years). Subse-
quently, the current findings need to be verified in a large
prospective clinical trial.
Conclusion
The present study showed a relatively benign prognosis
during long-term follow-up in a majority of the Caucasian
patients with coronary artery spasm, presenting with ACS
and/or OHCA. Both the role of ICD in OHCA secondary
to coronary spasm and the efficacy of stenting to treat
vasospastic angina warrant further study in large-sized
prospective clinical trials.
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